StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
TRVIBullishCorporate Developmentsnews
High materiality8/10

Trevi Therapeutics to Raise $150 Million Through Public Offering

Apr 16, 2026, 10:45 PM EDT2 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The capital raise could positively affect growth prospects, similar to other biopharma equity offerings that funded successful developments.

AI summary

What happened, with direct paths to the underlying reporting

Trevi Therapeutics has launched a public offering of 11.6 million shares at $13 each, aiming to raise approximately $150 million. This funding will likely support the development of Haduvio, its investigational therapy for chronic cough, enhancing their financial position and clinical efforts.

  • Trevi Therapeutics announced a public offering of 11.6 million shares.
  • Shares priced at $13.00, raising approximately $150 million.
  • Offering closes on or about April 20, 2026, pending conditions.
  • Underwriters have a 30-day option for an additional 1.74 million shares.
  • Haduvio targets chronic cough, showing significant clinical trial success.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event